Anne-Sophie Garcia is a seasoned professional in the pharmaceutical industry with significant expertise in regulatory affairs and pharmaceutical development. Currently serving as the Head of Development & Industrialization at Stragen, Garcia has previously held key positions including Senior Consultant in Pharmaceutical Development at ASG Consulting, Director of Licensing and Regulatory Affairs at Arrow génériques (now Aurobindo group), Director of Regulatory Affairs at Arrow génériques, and Regulatory Affairs Manager at Merck Génériques (now part of the Viatris group). This extensive background underscores a strong proficiency in navigating regulatory landscapes and advancing pharmaceutical initiatives.